CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration

被引:3
|
作者
Cheng, Chung-wah [1 ]
Wu, Tai-xiang [2 ]
Shang, Hong-cai [4 ]
Li, You-ping [3 ]
Altman, Douglas G. [5 ]
Moher, David [6 ]
Bian, Zhao-xiang [1 ]
机构
[1] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong Chinese Med Clin Study Ctr, 3-F,Jockey Club Sch Chinese Med Bldg, Kowloon Tong, Hong Kong, Peoples R China
[2] Sichuan Univ, Chinese Cochrane Ctr, West China Hosp, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, Chinese Evidence Based Med Ctr, Dept Clin Epidemiol, West China Hosp, Chengdu, Sichuan, Peoples R China
[4] Beijing Univ Chinese Med, Key Lab Chinese Internal Med, Minist Educ & Beijing, Dongzhimen Hosp, Beijing, Peoples R China
[5] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England
[6] Univ Ottawa, Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada
关键词
RANDOMIZED CONTROLLED-TRIALS; INTERVENTIONS; JOURNALS;
D O I
10.7326/M16-2977
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chinese herbal medicine (CHM) formulas are the major components of traditional Chinese medicine (TCM) interventions. The general reporting quality of randomized controlled trials (RCTs) of CHM formulas is disappointing, although CONSORT (Consolidated Standards of Reporting Trials) Statement extensions for herbal medicinal interventions and acupuncture interventions are available. A group of TCM clinical experts, methodologists, epidemiologists, and editors has developed this CONSORT Extension for CHM Formulas (CONSORT-CHM Formulas 2017) through a comprehensive process, including publication of the draft version, solicitation of comments, revision, and finalization. The CONSORT 2010 Statement was extended by introducing the idea of TCM Pattern and the features of CHM formulas. One new checklist subitem, keywords, was added to facilitate indexing and data searching. Seven of the 25 CONSORT checklist items, namely title and abstract, background and objectives, participants, interventions, outcomes, generalizability, and interpretation, are now elaborated, and the explanation of harms specific to CHM formulas is revised. Illustrative examples and explanations are also provided. The group hopes that CONSORT-CHM Formulas 2017 can improve the reporting quality of RCTs of CHM formulas.
引用
收藏
页码:112 / 121
页数:10
相关论文
共 48 条
  • [1] CONSORT extension for reporting N-of-1 trials for traditional Chinese medicine (CENT for TCM) : Recommendations, explanation and elaboration
    Li, Jiang
    Hu, Jia-yuan
    Zhai, Jing-bo
    Niu, Jun-qiang
    Kwong, Joey S. W.
    Ge, Long
    Li, Bo
    Wang, Qi
    Wang, Xiao-qin
    Wei, Dang
    Tian, Jin-hui
    Ma, Bin
    Yang, Ke-hu
    Dai, Min
    Tian, Gui-hua
    Shan, Hong-cai
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 46 : 180 - 188
  • [2] Randomized Trials of Chinese Herbal Medicine: A New Extension of the CONSORT Statement
    Linde, Klaus
    Brinkhaus, Benno
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (02) : 133 - +
  • [3] The reporting quality of randomized controlled trials in Chinese herbal medicine (CHM) formulas for diabetes based on the consort statement and its extension for CHM formulas
    Liu, Yan
    Hu, Chaoyue
    Zhou, Kehua
    Zhang, Ye
    Kang, Jing
    Wen, Yalu
    Yuan, Ruyue
    Li, Jiaoyue
    Zhao, Qiyao
    Zhang, Li
    Yang, Xiaohui
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [4] WHO Trial Registration Data Set (TRDS) extension for traditional Chinese medicine 2020: recommendations, explanation, and elaboration
    Xuan Zhang
    Liang Lan
    Jacky C. P. Chan
    Linda L. D. Zhong
    Chung-Wah Cheng
    Wai-Ching Lam
    Ran Tian
    Chen Zhao
    Tai-Xiang Wu
    Hong-Cai Shang
    Ai-Ping Lyu
    Zhao-Xiang Bian
    BMC Medical Research Methodology, 20
  • [5] WHO Trial Registration Data Set (TRDS) extension for traditional Chinese medicine 2020: recommendations, explanation, and elaboration
    Zhang, Xuan
    Lan, Liang
    Chan, Jacky C. P.
    Zhong, Linda L. D.
    Cheng, Chung-Wah
    Lam, Wai-Ching
    Tian, Ran
    Zhao, Chen
    Wu, Tai-Xiang
    Shang, Hong-Cai
    Lyu, Ai-Ping
    Bian, Zhao-Xiang
    BMC MEDICAL RESEARCH METHODOLOGY, 2020, 20 (01)
  • [6] PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration
    Xuan Zhang
    Ran Tan
    Wai Ching Lam
    Chung Wah Cheng
    Liang Yao
    Xiao-Qin Wang
    Si-Yao Li
    Qi-Ying Aixinjueluo
    Ke-Hu Yang
    Hong-Cai Shang
    Tai-Xiang Wu
    Ai-Ping Lyu
    Zhao-Xiang Bian
    Systematic Reviews, 9
  • [7] PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration
    Zhang, Xuan
    Tan, Ran
    Lam, Wai Ching
    Cheng, Chung Wah
    Yao, Liang
    Wang, Xiao-Qin
    Li, Si-Yao
    Aixinjueluo, Qi-Ying
    Yang, Ke-Hu
    Shang, Hong-Cai
    Wu, Tai-Xiang
    Lyu, Ai-Ping
    Bian, Zhao-Xiang
    SYSTEMATIC REVIEWS, 2020, 9 (01)
  • [8] The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation
    Xie, Runsheng
    Xia, Yun
    Chen, Yaolong
    Li, Hui
    Shang, Hongcai
    Kuang, Xinying
    Xia, Linjun
    Guo, Yi
    PHARMACOLOGICAL RESEARCH, 2020, 160
  • [9] Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018)
    Liang Dai
    Chung-wah Cheng
    Ran Tian
    Linda LD Zhong
    You-ping Li
    Ai-ping Lyu
    An-wen Chan
    Hong-cai Shang
    Zhao-xiang Bian
    Chinese Journal of Integrative Medicine, 2019, 25 : 71 - 79
  • [10] Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration(SPIRIT-TCM Extension 2018)
    DAI Liang
    CHENG Chung-wah
    TIAN Ran
    ZHONG Linda LD
    LI You-ping
    LYU Ai-ping
    CHAN An-wen
    SHANG Hong-cai
    BIAN Zhao-xiang
    Chinese Journal of Integrative Medicine, 2019, 25 (01) : 71 - 79